biote Corp.

Symbol: BTMDW

PNK

1.36

USD

Market price today

  • -18.7805

    P/E Ratio

  • -0.5074

    PEG Ratio

  • 0.00M

    MRK Cap

  • 0.00%

    DIV Yield

biote Corp. (BTMDW) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.68%

Operating Profit Margin

0.18%

Net Profit Margin

-0.06%

Return on Assets

-0.07%

Return on Equity

0.27%

Return on Capital Employed

0.25%

Company general description and statistics

Sector: Healthcare
Industry: Medical Care Facilities
CEO:Mr. Marc D. Beer
Full-time employees:
City:Irving
Address:1875 West Walnut Hill Lane
IPO:2022-05-27
CIK:0001819253

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

General Outlook

When we look at how much money they make before expenses, they keep 0.680% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.179%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.061%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.073% return, is a testament to biote Corp.'s adeptness in optimizing resource deployment. biote Corp.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.274%. Furthermore, the proficiency of biote Corp. in capital utilization is underscored by a remarkable 0.250% return on capital employed.

Stock Prices

biote Corp.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1.22, while its low point bottomed out at $1.2. This variance in figures offers investors a lucid insight into the roller-coaster ride that is biote Corp.'s stock market.

Liquidity Ratios

Analyzing BTMDW liquidity ratios reveals its financial health of the firm. The current ratio of 550.72% gauges short-term asset coverage for liabilities. The quick ratio (437.43%) assesses immediate liquidity, while the cash ratio (400.64%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio550.72%
Quick Ratio437.43%
Cash Ratio400.64%

Profitability Ratios

BTMDW profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -0.07% underscores its earnings before tax deductions. The effective tax rate stands at -2180.49%, revealing its tax efficiency. The net income per EBT, 9194.31%, and the EBT per EBIT, -0.37%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 17.92%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-0.07%
Effective Tax Rate-2180.49%
Net Income per EBT9194.31%
EBT per EBIT-0.37%
EBIT per Revenue17.92%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 5.51, it details the span from stock purchase to revenue. The 4 days it takes to settle debts showcases its creditor relations. Meanwhile, a 4 cash conversion cycle and 2267.68% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding437
Days of Inventory Outstanding129
Operating Cycle144.83
Days of Payables Outstanding26
Cash Conversion Cycle119
Receivables Turnover22.68
Payables Turnover14.29
Inventory Turnover2.84
Fixed Asset Turnover59.89
Asset Turnover1.19

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.79, and free cash flow per share, 0.71, depict cash generation on a per-share basis. The cash per share value, 2.62, showcases liquidity position. A payout ratio of -0.77 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.15, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.79
Free Cash Flow per Share0.71
Cash per Share2.62
Payout Ratio-0.77
Operating Cash Flow Sales Ratio0.15
Free Cash Flow to Operating Cash Flow Ratio0.90
Cash Flow Coverage Ratio0.24
Short Term Coverage Ratio4.10
Capital Expenditure Coverage Ratio9.91
Dividend Paid and Capex Coverage Ratio2.36
Dividend Payout Ratio0.07

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 72.89%, highlights its total liabilities relative to assets. With a debt-equity ratio of -3.85, we discern the balance between debt and equity financing. The long-term debt to capitalization, 138.06%, and total debt to capitalization, 135.08%, ratios shed light on its capital structure. An interest coverage of 4.13 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio72.89%
Debt Equity Ratio-3.85
Long Term Debt to Capitalization138.06%
Total Debt to Capitalization135.08%
Interest Coverage4.13
Cash Flow to Debt Ratio0.24
Company Equity Multiplier-5.28

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 7.21, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.13, reflects the portion of profit attributed to each share. The book value per share, -1.14, represents the net asset value distributed per share, while the tangible book value per share, -1.61, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share7.21
Net Income Per Share0.13
Book Value Per Share-1.14
Tangible Book Value Per Share-1.61
Shareholders Equity Per Share-1.14
Interest Debt Per Share4.65
Capex Per Share-0.11

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 18.34%, indicates top-line expansion, while the gross profit growth, 21.86%, reveals profitability trends. EBIT growth, -275.70%, and operating income growth, -275.70%, offer insights into operational profitability progression.

cards.indicatorcards.value
Revenue Growth18.34%
Gross Profit Growth21.86%
EBIT Growth-275.70%
Operating Income Growth-275.70%
Net Income Growth-95.94%
Operating Cash Flow Growth-127.16%
Free Cash Flow Growth-136.76%
Receivables Growth32.82%
Inventory Growth16.31%
Asset Growth105.49%
Debt Growth222.53%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 152,873,154.42, captures the company's total value, considering both debt and equity. Income quality, 8.11, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 3.20%, indicates the value of non-physical assets, and capex to operating cash flow, -10.09%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value152,873,154.42
Income Quality8.11
Intangibles to Total Assets3.20%
Capex to Operating Cash Flow-10.09%
Capex to Revenue-1.46%
Capex to Depreciation-90.61%
Stock-Based Compensation to Revenue4.89%
Graham Number1.82
Return on Tangible Assets2.21%
Graham Net Net-3.35
Working Capital100,128,000
Tangible Asset Value-41,519,000
Net Current Asset Value-69,498,000
Invested Capital-4
Average Receivables7,560,999.5
Average Payables4,133,500
Average Inventory16,064,000
Days Sales Outstanding16
Days Payables Outstanding25
Days of Inventory On Hand126
ROIC1176.28%
ROE-0.11%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -7.22, and the price to book ratio, -7.22, reflect the market's valuation relative to the company's book value. The price to sales ratio, 2.19, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 16.82, and price to operating cash flows, 7.90, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio-7.22
Price to Book Ratio-7.22
Price to Sales Ratio2.19
Price Cash Flow Ratio7.90
Price Earnings to Growth Ratio-0.51
Enterprise Value Multiple10.05
Price Fair Value-7.22
Price to Operating Cash Flow Ratio7.90
Price to Free Cash Flows Ratio16.82
Price to Tangible Book Ratio-4.32
Enterprise Value to Sales0.82
Enterprise Value Over EBITDA3.31
EV to Operating Cash Flow5.69
Earnings Yield2.61%
Free Cash Flow Yield19.03%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of biote Corp. (BTMDW) on the PNK in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -18.781 in 2024.

What is the ticker symbol of biote Corp. stock?

The ticker symbol of biote Corp. stock is BTMDW.

What is company IPO date?

IPO date of biote Corp. is 2022-05-27.

What is company current share price?

Current share price is 1.360 USD.

What is stock market cap today?

The market cap of stock today is 0.000.

What is PEG ratio in 2024?

The current -0.507 is -0.507 in 2024.

What is the number of employees in 2024?

In 2024 the company has 0.